Literature DB >> 2056277

Major histocompatibility complex independent T cell receptor-antigen interaction: functional analysis using fluorescein derivatives.

D J Diamond1, P Szalay, D Symer, P Hao, H S Shin, R Z Dintzis, H M Dintzis, E L Reinherz, R F Siliciano.   

Abstract

We have isolated T cell receptor (TCR) cDNAs from fluorescein (FL)-specific human T cell clones (alpha FL beta FL), and transferred them to TCR beta- Jurkat cells in order to study direct FL-binding to the TCR. Using either FL-conjugated polymers (FL-polymer) or FL-substituted Sepharose beads, we are able to demonstrate the direct binding of antigen to the T cell surface, and the functional activation of the T cell transfectants. We present evidence against the involvement of major histocompatibility complex (MHC) molecules or antigen presentation in the interaction of FL with the alpha FL beta FL transfectants. Additionally, we have examined the effect of ring substitutions on the FL molecule as well as specific alterations of substituents attached to the 5' position, and we have found that all of them interfere with the functional recognition of the alpha FL beta FL TCR. These experiments demonstrate that TCRs like antibodies have intrinsic affinities for antigen, even without the involvement of MHC molecules.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2056277      PMCID: PMC2118876          DOI: 10.1084/jem.174.1.229

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  45 in total

1.  Transfer of specificity by murine alpha and beta T-cell receptor genes.

Authors:  Z Dembić; W Haas; S Weiss; J McCubrey; H Kiefer; H von Boehmer; M Steinmetz
Journal:  Nature       Date:  1986 Mar 20-26       Impact factor: 49.962

2.  Organization and sequences of the variable, joining and constant region genes of the human T-cell receptor alpha-chain.

Authors:  Y Yoshikai; S P Clark; S Taylor; U Sohn; B I Wilson; M D Minden; T W Mak
Journal:  Nature       Date:  1985 Aug 29-Sep 4       Impact factor: 49.962

3.  Binding of immunogenic peptides to Ia histocompatibility molecules.

Authors:  B P Babbitt; P M Allen; G Matsueda; E Haber; E R Unanue
Journal:  Nature       Date:  1985 Sep 26-Oct 2       Impact factor: 49.962

4.  The interaction of nominal antigen with T cell antigen receptors. I. Specific binding of multivalent nominal antigen to cytolytic T cell clones.

Authors:  R F Siliciano; A D Keegan; R Z Dintzis; H M Dintzis; H S Shin
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

5.  Genomic organization and sequence of T-cell receptor beta-chain constant- and joining-region genes.

Authors:  N R Gascoigne; Y Chien; D M Becker; J Kavaler; M M Davis
Journal:  Nature       Date:  1984 Aug 2-8       Impact factor: 49.962

6.  Reconstitution of an active surface T3/T-cell antigen receptor by DNA transfer.

Authors:  P S Ohashi; T W Mak; P Van den Elsen; Y Yanagi; Y Yoshikai; A F Calman; C Terhorst; J D Stobo; A Weiss
Journal:  Nature       Date:  1985 Aug 15-21       Impact factor: 49.962

7.  A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus.

Authors:  B Sugden; K Marsh; J Yates
Journal:  Mol Cell Biol       Date:  1985-02       Impact factor: 4.272

8.  Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.

Authors:  J L Yates; N Warren; B Sugden
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

9.  Binding of antigen in the absence of histocompatibility proteins by arsonate-reactive T-cell clones.

Authors:  A Rao; W W Ko; S J Faas; H Cantor
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

10.  Activation of a human T cell line: a two-stimulus requirement in the pretranslational events involved in the coordinate expression of interleukin 2 and gamma-interferon genes.

Authors:  R Wiskocil; A Weiss; J Imboden; R Kamin-Lewis; J Stobo
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

View more
  8 in total

1.  Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones.

Authors:  B Schnyder; D Mauri-Hellweg; M Zanni; F Bettens; W J Pichler
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 2.  Special regulatory T-cell review: A rose by any other name: from suppressor T cells to Tregs, approbation to unbridled enthusiasm.

Authors:  Ronald N Germain
Journal:  Immunology       Date:  2008-01       Impact factor: 7.397

3.  Induction of tolerance by administration of hapten-immunoglobulin conjugates is associated with decreased IL-2 and IL-4 production.

Authors:  V Dumas; W Ptak; M Demarchez; J H Saurat; Y Borel; C Hauser
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

4.  A soluble, single-chain T-cell receptor fragment endowed with antigen-combining properties.

Authors:  J Novotny; R K Ganju; S T Smiley; R E Hussey; M A Luther; M A Recny; R F Siliciano; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

5.  Components of the ligand for a Ni++ reactive human T cell clone.

Authors:  Linh Lu; Jörg Vollmer; Corinne Moulon; Hans Ulrich Weltzien; Philippa Marrack; John Kappler
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

6.  The Fate of a Hapten - From the Skin to Modification of Macrophage Migration Inhibitory Factor (MIF) in Lymph Nodes.

Authors:  Isabella Karlsson; Kristin Samuelsson; Carl Simonsson; Anna-Lena Stenfeldt; Ulrika Nilsson; Leopold L Ilag; Charlotte Jonsson; Ann-Therese Karlberg
Journal:  Sci Rep       Date:  2018-02-13       Impact factor: 4.379

Review 7.  T cells and their eons-old obsession with MHC.

Authors:  Lei Yin; James Scott-Browne; John W Kappler; Laurent Gapin; Philippa Marrack
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

8.  Inhibition or activation of human T cell receptor transfectants is controlled by defined, soluble antigen arrays.

Authors:  D E Symer; R Z Dintzis; D J Diamond; H M Dintzis
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.